Balaxi Pharmaceuticals Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Jun '25
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Total Qtr Revenue cr
    68.97
    74.57
    77.23
    73.27
    63.77
    Other Income Qtr Cr-1.78-1.693.94-4.11-1.85
    Operating Revenues Qtr70.7476.2773.2977.3865.62
    Loading chart...
    Operating Expenses Qtr
    66.59
    63.71
    69.30
    66.79
    55.54
    Operating Profit Qtr
    4.15
    12.55
    3.99
    10.59
    10.09
    EBITDA Qtr Cr
    2.37
    10.86
    7.93
    6.48
    8.24
    Depreciation Qtr
    0.46
    0.46
    0.48
    0.46
    0.49
    Net Profit Qtr
    0.29
    8.64
    5.36
    4.59
    6.48
    Basic EPS Qtr
    0.05
    1.56
    0.97
    0.84
    1.17
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -